医学
细胞疗法
免疫抑制
调节性T细胞
移植
免疫学
不利影响
细胞
内科学
免疫系统
T细胞
白细胞介素2受体
生物
遗传学
作者
Satoru Todo,Kenichiro Yamashita,Ryoichi Goto,Masaaki Zaitsu,Akihisa Nagatsu,Tetsu Oura,Masaaki Watanabe,Takeshi Aoyagi,Tomomi Suzuki,Tsuyoshi Shimamura,Toshiya Kamiyama,Norihiro Sato,Junichi Sugita,Kanako C. Hatanaka,Hisashi Bashuda,Sonoko Habu,Anthony J. Demetris,Ko Okumura
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2016-01-16
卷期号:64 (2): 632-643
被引量:417
摘要
A cell therapy using an ex vivo-generated regulatory T-cell-enriched cell product is safe and effective for drug minimization and operational tolerance induction in living donor liver recipients with nonimmunological liver diseases. (Hepatology 2016;64:632-643).
科研通智能强力驱动
Strongly Powered by AbleSci AI